Octreotide Long-Acting Injection and Tisagenlecleucel Intravenous
Determining the interaction of Octreotide Long-Acting Injection and Tisagenlecleucel Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
Generic Name: tisagenlecleucel
Brand name: Kymriah
Synonyms: Tisagenlecleucel
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Octreotide Long-Acting Injection-Titralac
- Octreotide Long-Acting Injection-Tivicay
- Octreotide Long-Acting Injection-Tivicay (Dolutegravir 10 mg)
- Octreotide Long-Acting Injection-Tivicay (Dolutegravir 25 mg and 50 mg)
- Octreotide Long-Acting Injection-Tivorbex
- Octreotide Long-Acting Injection-Tizanidine
- Tisagenlecleucel Intravenous-Ocu-Carpine
- Tisagenlecleucel Intravenous-Ocu-Chlor
- Tisagenlecleucel Intravenous-Ocu-Dex
- Tisagenlecleucel Intravenous-Ocu-Disal
- Tisagenlecleucel Intravenous-Ocu-Pentolate
- Tisagenlecleucel Intravenous-Ocu-Phrin